Evidence map›Paper›PMID 40453882›Full record

ReviewOpen forum infectious diseases2025

Hepatitis C Treatment Initiation During Hospitalization for People Who Use Drugs: A Narrative Review of the Literature.

Jacob Denkins, Jane Babiarz, YoungYoon Ham, HaYoung Ryu, Brian Ricci, Carissa Williams, Ian Alexander, Kendall Tucker, L Madeline McCrary, Ximena Levander

Abstract readReview
In one paragraph

Review in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jacob DenkinsDepartment of Pharmacy, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0009-0001-7720-2546
Jane BabiarzDivision of Internal Medicine and Geriatrics, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0000-0002-4532-9323
YoungYoon HamDepartment of Pharmacy, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0000-0002-5644-4896
HaYoung RyuDepartment of Pharmacy, Oregon Health & Science University, Portland, Oregon, USA.
Brian RicciDivision of Internal Medicine and Geriatrics, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0000-0002-2532-6635
Carissa WilliamsDivision of General Internal Medicine and Geriatrics, Department of Care Management, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0009-0003-8330-3778
Ian AlexanderDivision of General Internal Medicine and Geriatrics, Department of Care Management, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0009-0003-8235-0484
Kendall TuckerDepartment of Pharmacy Practice, College of Pharmacy, Oregon State University, Portland, Oregon, USA.ORCID https://orcid.org/0000-0001-5868-0449
L Madeline McCraryDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
Ximena LevanderSection of Addiction Medicine, Division of General Internal Medicine and Geriatrics, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.ORCID https://orcid.org/0000-0003-4919-7492

Funding

Vanderbilt Oregon COllaborative Scholar Training in Addiction Research (COSTAR)K12DA061526 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW S FREIBERG, Philip Todd Korthuis · 2024 to 2026
$1.5M
NIDA NIH HHS K12 DA061526
6 · The paper itself

Abstract

People who use drugs (PWUD) are increasingly acquiring and transmitting hepatitis C virus (HCV) and being admitted to the hospital for often costly non-HCV-related conditions. Traditionally, treatment of HCV has been deferred to the outpatient setting. However, outpatient HCV follow-up can be an arduous process to navigate with resultant gaps in care, especially for PWUD with numerous complex psychosocial and medical comorbidities. Hospitalization presents a key opportunity to initiate treatment, and several institutions have piloted inpatient treatment models with intensive outreach. We conducted a narrative review of peer-reviewed literature (2014-2024) evaluating hospital-based HCV treatment models for PWUD; 6 studies from 4 countries met inclusion criteria. Evidence suggests that engaging PWUD during hospitalization leads to higher treatment initiation and completion as compared with standard-of-care outpatient referral. Inpatient HCV treatment models should be one part of a comprehensive plan in the United States and internationally to eliminate HCV for all.

Indexed as

hepatitis C virushospitalizationpeople who use drugstransitional carevulnerable populations

Identifiers

PMID40453882
PMCPMC12125678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.